2018

31 DEC 2018
VOLUNTARY ANNOUNCEMENT POSSIBLE CHANGE IN SHAREHOLDING OF AN INDIRECT MINORITY SHAREHOLDER OF THE COMPANY
28 DEC 2018
Terms of Reference of Remuneration Committee
28 DEC 2018
Terms of Reference of Nomination Committee
05 NOV 2018
VOLUNTARY ANNOUNCEMENT PATENT COOPERATION TREATY PATENT APPLICATION
01 OCT 2018
LAPSE OF THE DISPOSAL AGREEMENT IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY
06 SEP 2018
VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE BUY-BACK
03 SEP 2018
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
03 SEP 2018
RESIGNATION OF EXECUTIVE DIRECTOR
02 SEP 2018
UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
31 AUG 2018
FURTHER EXTENSION OF LONG STOP DATE OF THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY
27 AUG 2018
POSITIVE PROFIT ALERT
24 AUG 2018
FURTHER DELAY IN DESPATCH OF CIRCULAR FOR THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY
20 AUG 2018
DATE OF BOARD MEETING
31 JUL 2018
EXTENSION OF LONG STOP DATE OF THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY
23 JUL 2018
DELAY IN DESPATCH OF CIRCULAR FOR THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY
18 JUL 2018
DELAY IN DESPATCH OF CIRCULAR FOR THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY
27 JUN 2018
MAJOR TRANSACTION DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY
06 JUN 2018
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 6 JUNE 2018
03 MAY 2018
COMPLETION OF DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF REMAINING 40% EQUITY INTEREST IN TONGFANG PHARMACEUTICAL INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE
26 APR 2018
NOTICE OF ANNUAL GENERAL MEETING
24 APR 2018
DISCLOSEABLE AND CONNECTED TRANSACTION EXTENSION OF LOANS
24 APR 2018
DISCLOSEABLE TRANSACTION IN RELATION TO THE PROVISION OF LOAN
28 MAR 2018
ANNOUNCEMENT OF AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
16 MAR 2018
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 16 MARCH 2018
15 MAR 2018
VOLUNTARY ANNOUNCEMENT
15 MAR 2018
DATE OF BOARD MEETING
05 MAR 2018
FURTHER ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION AND CONTINUING CONNECTED TRANSACTION RELATING TO THE FRANCHISE AGREEMENT
26 FEB 2018
NOTICE OF EXTRAORDINARY GENERAL MEETING
13 FEB 2018
DELAY IN DESPATCH OF CIRCULAR FOR THE DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF REMAINING 40% EQUITY INTEREST IN TONGFANG PHARMACEUTICAL GROUP CO., LTD* INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE
23 JAN 2018
(I) ISSUE OF NEW SHARES UNDER GENERAL MANDATE AND (II) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF REMAINING 40% EQUITY INTEREST IN TONGFANG PHARMACEUTICAL GROUP CO., LTD* INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE
23 JAN 2018
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
23 JAN 2018
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF EXECUTIVE DIRECTOR

Back to top

Copyright 2019 Tongfang Kontafarma Holdings Limited. All rights reserved.  |  DISCLAIMER  |  SITEMAP  |  CONTACT US